Back to search
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase I trial tests the safety, side effects, best dose and effectiveness of lenalidomide when added to nivolumab and the usual drugs (rituximab and methot…
This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 ad…
DALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in…
This study is evaluating whether an experimental treatment called GLPG5101 helps to treat non-Hodgkin lymphoma (NHL) and if it is safe to use. This study will…
This phase II trial studies how well nivolumab with or without varlilumab works in treating patients with aggressive B-cell lymphomas that have come back (recur…